Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Search Results

Refine Your Search

By Sector

Sort by: Date|Relevance

Buzz on the Bullboards: Six More Weeks of Volatility?

If you haven’t heard, the groundhog saw his shadow, and if the snowfall on the East and West coasts weren’t enough of an indication, it looks like winter may be with us for awhile still … along with COVID and its variants, which are still a...

Buzz on the Bullboards: The Best Opportunities in Mining, Tech, & Cannabis?

(Image via HEXO Corp.) Canada’s largest financial portal for Canadian small-cap investors is right here at Stockhouse. It is where our Bullboards – your Bullboards – are a leading forum to discuss these Canadian-listed small-cap businesses. Wan...

Buzz on the Bullboards: The Cannabis Deal of a Lifetime?

(Image via Aphria Inc.) The fate of one of the biggest mergers in cannabis’ young history as a legal market will be decided tomorrow, when shareholders of Leamington ON-based licensed producer Aphria Inc. ( TSX: APHA , Forum ) vote on whet...

The New Age of Advertising

With my involvement at Heelo, I have learned a lot about the new advertising world. There has been and still is a huge transformation taking place to digital advertising. You have experience with this from Google and Facebook that along with YouTube see the most web traf...

A New Solution for the Multibillion-Dollar Bladder Cancer Problem

Bladder cancer is the sixth-most prevalent cancer in North America and has a recurrence rate greater than 50%, making it the most expensive cancer to treat. All-in costs in the US are around $4 billion and roughly 80,000 new American cases are reported each year, with 350,000...

Breaking Down the Multibillion-Dollar Biologicals Market

(Click to play video) Investors aware of the biologicals market know that it has been quietly building up over the last few years. From mergers and acquisition deals north of a billion dollars to a steady presence in industry and mainstream news, the sector is o...

The Depravity of the False Flag

"Never let a good crisis go to waste." —Sir Winston Churchill My late older brother Donnie was a quasi-anarchist tax collector for the Canadian government who self-educated himself and then morphed from a grumbling, cynical security guard/starving artist to a very succe...

Draganfly Holds 'Pole Position' in Race for Drone Supremacy After Chinese Barred from US Market

The company establishes a toehold with U.S. government, homeland security and military contractors, and readies drones to screen for the coronavirus. With the growing concern of the theft of intellectual property from the likes of Huawei cell networks and Ch...

Understanding Fortress Biotech

Daniel Carlson of Tailwinds Research takes a close look at what he calls a "great value opportunity," with a focus on subsidiary Avenue Therapeutics. With a plethora of balls in the air, Fortress Biotech Inc. (FBIO:NASDAQ) is a very difficult company to va...

Titans in Mining: An Interview with Rick Rule, Part I

The Critical Investor sits down with Rick Rule, CEO of Sprott U.S. Holdings, for a wide-ranging discussion of his more than four-decade-long involvement in the resource sector. Several months ago I thought of something different. Wouldn't it be nice to interview the...
1 2 3